Drugs / HES
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01117649 | May 2010 → Jul 2012 | pancreas disorder | B. Braun Melsungen AG | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HES | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01117649 ↗ |